| Prostaglandin G/H synthase 1 |
8.1 |
Aspirin |
COX1 |
|
|
| HLA class I histocompatibility antigen, B-39 alpha chain |
7.8 |
Aspirin |
HLA-B |
|
|
| Deoxyribonuclease-1-like 1 |
7.6 |
Aspirin |
DNASE1L1 |
|
|
| Cytochrome P450 1A2 |
7.5 |
Aspirin |
CYP1A2 |
|
|
| Heparanase |
7.3 |
Aspirin |
HPSE |
|
|
| Serum albumin |
7.2 |
Aspirin |
ALB |
|
|
| Ephrin type-A receptor 8 |
7.2 |
Aspirin |
EPHA8 |
|
|
| Heat shock cognate 71 kDa protein |
7.1 |
Aspirin |
HSPA8 |
|
|
| Proteinase-activated receptor 1 (PAR1) |
7.0 |
Aspirin |
F2R |
|
|
| P2X purinoceptor 4 (P2X4) |
6.9 |
Aspirin |
P2RX4 |
|
|
| Angiotensin II type-2 (AT2) receptor |
6.8 |
Aspirin |
AGTR2 |
|
|
| Prostaglandin G/H synthase 2 |
6.7 |
Aspirin |
COX2 |
|
|
| Cathepsin G |
6.6 |
Aspirin |
CTSG |
|
|
| Angiotensin-converting enzyme |
6.5 |
Aspirin |
ACE |
|
|
| P2Y purinoceptor 1 (P2Y1) |
11.8 |
Cilostazol |
P2RY1 |
|
|
| Heparanase |
11.5 |
Cilostazol |
HPSE |
|
|
| Ephrin type-A receptor 8 |
11.1 |
Cilostazol |
EPHA8 |
|
|
| Cathepsin G |
11.0 |
Cilostazol |
CTSG |
|
|
| Serum albumin |
10.9 |
Cilostazol |
ALB |
|
|
| Heat shock cognate 71 kDa protein |
10.9 |
Cilostazol |
HSPA8 |
|
|
| Angiotensin II type-2 (AT2) receptor |
10.9 |
Cilostazol |
AGTR2 |
|
|
| P2X purinoceptor 4 (P2X4) |
10.8 |
Cilostazol |
P2RX4 |
|
|
| Angiotensin-converting enzyme |
10.6 |
Cilostazol |
ACE |
|
|
| Angiotensin II Type-1 (AT1) receptor |
10.1 |
Cilostazol |
AGTR1 |
|
|
| cGMP-inhibited 3′,5′-cyclic phosphodiesterase A |
9.8 |
Cilostazol |
PDE3A |
|
|
| Proteinase-activated receptor 4 (PAR4) |
9.7 |
Cilostazol |
F2RL3 |
|
|
| P2Y purinoceptor 12 (P2Y12) |
9.4 |
Cilostazol |
P2RY12 |
|
|
